ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

640
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullish•Cross Asset Strategy
•27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
439 Views
Share
bearish•Bombardier Inc
•16 Nov 2018 11:07

Reality Overwhelms Creative Accounting

Bombardier Inc (BBD/B CN) has recently fallen 38%, ThyssenKrupp AG (TKA GR) 18%  and Celltrion Inc (068270 KS) 30%.  In each case, the market was...

bullish•Samsung C&T
•15 Nov 2018 08:12

Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T

The FSC said it had found intentionality behind BioLogics’ breach of accounting rules. Hence, the FSC pressed criminal charges against BioLogics...

Logo
602 Views
Share
•31 Oct 2018 21:23

Korea Stock Market Monthly Recap #30 (October 2018)

The Korean stock market fell sharply in October and KOSPI is down 13% this month. Nikkei is down 9% and S&P 500 is down 8% this month as well....

Logo
614 Views
Share
•29 Oct 2018 13:52

Smartkarma’s Week That Was in JP/​​​​KR: Market Turbulence 10 Years After 2008, Coway, & Celltrion

The Korean and Japanese stock markets have fallen sharply in October. Nikkei is down 12% and KOSPI is down 14% in October. It has been 10 years...

Logo
413 Views
Share
x